These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 3986005)
41. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study. Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294 [TBL] [Abstract][Full Text] [Related]
42. Relationship between bone mineral content and frequency of postmenopausal fractures. Jensen GF; Christiansen C; Boesen J; Hegedüs V; Transbøl I Acta Med Scand; 1983; 213(1):61-3. PubMed ID: 6829322 [TBL] [Abstract][Full Text] [Related]
43. Bone safety of low-dose glucocorticoids in rheumatic diseases. Saag KG Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076 [TBL] [Abstract][Full Text] [Related]
44. Does bone measurement on the radius indicate skeletal status? Concise communication. Mazess RB; Peppler WW; Chesney RW; Lange TA; Lindgren U; Smith E J Nucl Med; 1984 Mar; 25(3):281-8. PubMed ID: 6699720 [TBL] [Abstract][Full Text] [Related]
45. Total and local bone mass before and after normalization for indices of bone and body size. Nilas L; Gotfredsen A; Christiansen C Scand J Clin Lab Invest; 1986 Feb; 46(1):53-7. PubMed ID: 3952441 [TBL] [Abstract][Full Text] [Related]
46. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699 [TBL] [Abstract][Full Text] [Related]
47. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study. Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766 [TBL] [Abstract][Full Text] [Related]
48. Relationship between body composition and bone mass in women. Khosla S; Atkinson EJ; Riggs BL; Melton LJ J Bone Miner Res; 1996 Jun; 11(6):857-63. PubMed ID: 8725184 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926 [TBL] [Abstract][Full Text] [Related]
50. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Verstraeten A; Dequeker J Ann Rheum Dis; 1986 Oct; 45(10):852-7. PubMed ID: 3789820 [TBL] [Abstract][Full Text] [Related]
51. Longitudinal study of hand bone densitometry in rheumatoid arthritis. Deodhar AA; Brabyn J; Jones PW; Davis MJ; Woolf AD Arthritis Rheum; 1995 Sep; 38(9):1204-10. PubMed ID: 7575713 [TBL] [Abstract][Full Text] [Related]
52. Are glucocorticoids harmful to bone in early rheumatoid arthritis? Lems WF Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059 [TBL] [Abstract][Full Text] [Related]
53. The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis. Stojanovic A; Veselinovic M; Draginic N; Rankovic M; Andjic M; Bradic J; Bolevich S; Antovic A; Jakovljevic V Oxid Med Cell Longev; 2021; 2021():9458587. PubMed ID: 33505593 [TBL] [Abstract][Full Text] [Related]
54. [Osteoporotic changes in rheumatoid arthritis--longitudinal bone mass study and effect of 1 alpha-hydroxyvitamin D3]. Teshima R Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):171-8. PubMed ID: 3392446 [TBL] [Abstract][Full Text] [Related]
55. [Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach]. Macovei L; Ancuţa C; Pomîrleanu C; Chirieac R Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):470-6. PubMed ID: 23077939 [TBL] [Abstract][Full Text] [Related]
56. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy? Kotaniemi A; Piirainen H; Paimela L; Leirisalo-Repo M; Uoti-Reilama K; Lahdentausta P; Ruotsalainen P; Kataja M; Väisänen E; Kurki P J Rheumatol; 1996 Nov; 23(11):1875-9. PubMed ID: 8923359 [TBL] [Abstract][Full Text] [Related]
57. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007 [TBL] [Abstract][Full Text] [Related]
58. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study. Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825 [TBL] [Abstract][Full Text] [Related]
59. Reference charts for the relationships between dual-energy X-ray absorptiometry-assessed bone mineral content and lean mass in 3,063 healthy men and premenopausal and postmenopausal women. Cure-Cure C; Capozza RF; Cointry GR; Meta M; Cure-Ramírez P; Ferretti JL Osteoporos Int; 2005 Dec; 16(12):2095-106. PubMed ID: 16172799 [TBL] [Abstract][Full Text] [Related]
60. [Bone mineral density in patients with rheumatoid arthritis]. Macovei L; Ancuţa C; Belibou C; Chirieac R Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):723-30. PubMed ID: 22046778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]